Close Menu

NEW YORK – Qiagen reported after the close of the market on Tuesday that its second quarter revenues jumped 16 percent year over year due primarily to high demand for products related to SARS-CoV-2 molecular diagnostic testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.